Publications
151 results found
Kon OM, Hansel TT, Barnes PJ, 2008, Chronic Obstructive Pulmonary Disease, Great Britain, Publisher: Oxford University Press
Pettipher R, Hansel TT, 2008, Antagonists of the Prostaglandin D<sub>2</sub> Receptor CRTH2, DRUG NEWS & PERSPECTIVES, Vol: 21, Pages: 317-322, ISSN: 0214-0934
- Author Web Link
- Cite
- Citations: 33
Flood-Page P, Swenson C, Faiferman I, et al., 2007, A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 176, Pages: 1062-1071, ISSN: 1073-449X
- Author Web Link
- Cite
- Citations: 573
Pettipher R, Hansel TT, Armer R, 2007, Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases., Nat Rev Drug Discov, Vol: 6, Pages: 313-325, ISSN: 1474-1776
Immunological activation of mast cells is an important trigger in the cascade of inflammatory events leading to the manifestation of allergic diseases. Pharmacological studies using the recently discovered DP(1) and CRTH2 antagonists combined with genetic analysis support the view that these receptors have a pivotal role in mediating aspects of allergic diseases that are resistant to current therapy. This Review focuses on the emerging roles that DP(1) and CRTH2 (also known as DP(2)) have in acute and chronic aspects of allergic diseases and proposes that, rather than having opposing actions, these receptors have complementary roles in the initiation and maintenance of the allergy state. We also discuss recent progress in the discovery and development of selective antagonists of these receptors.
Hopkinson NS, Tennant RC, Dayer MJ, et al., 2007, A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease, RESPIRATORY RESEARCH, Vol: 8, ISSN: 1465-9921
- Author Web Link
- Open Access Link
- Cite
- Citations: 131
Erin EM, Onn MK, Barnes PJ, et al., 2007, From the authors [2], American Journal of Respiratory and Critical Care Medicine, Vol: 175, Pages: 288-289, ISSN: 1073-449X
Erin EM, Onn MK, Barnes PJ, et al., 2007, From the authors [2], American Journal of Respiratory and Critical Care Medicine, Vol: 175, Pages: 196-197, ISSN: 1073-449X
Nicholson GC, Tennant RC, Carpenter DC, et al., 2007, A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist, Pulmonary Pharmacology and Therapeutics, Vol: 20, Pages: 52-59, ISSN: 1094-5539
Erin EM, Leaker BR, Nicholson GC, et al., 2006, The effects of a monoclonal antibody directed against tumor necrosis factor-α in asthma (Retracted article. See vol. 183, pg. 418, 2011), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 174, Pages: 753-762, ISSN: 1073-449X
- Author Web Link
- Cite
- Citations: 220
Hansel TT, Benezet O, Kafe H, et al., 2006, A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma, CLINICAL THERAPEUTICS, Vol: 28, Pages: 906-920, ISSN: 0149-2918
- Author Web Link
- Cite
- Citations: 35
Erin EM, Leaker BR, Zacharasiewicz A, et al., 2006, Effects of a reversible β-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses, CLINICAL AND EXPERIMENTAL ALLERGY, Vol: 36, Pages: 458-464, ISSN: 0954-7894
- Author Web Link
- Cite
- Citations: 32
Gamble E, Qiu Y, Wang D, et al., 2006, Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design, EUROPEAN RESPIRATORY JOURNAL, Vol: 27, Pages: 293-299, ISSN: 0903-1936
- Author Web Link
- Cite
- Citations: 30
Erin EM, Leaker BR, Zacharasiewicz AS, et al., 2006, Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses, Clinical and Experimental Allergy, Vol: 36, Pages: 458-464, ISSN: 0954-7894
Hansel TT, Neighbour H, Erin EM, et al., 2005, Glycopyrrolate causes prolonged bronchoprotection and bronchodilatation in patients with asthma, CHEST, Vol: 128, Pages: 1974-1979, ISSN: 0012-3692
- Author Web Link
- Cite
- Citations: 59
Erin EM, Neighbour H, Tan AJ, et al., 2005, Nasal testing for novel anti-inflammatory agents, CLINICAL AND EXPERIMENTAL ALLERGY, Vol: 35, Pages: 981-985, ISSN: 0954-7894
- Author Web Link
- Cite
- Citations: 2
Zacharasiewicz A, Wilson N, Lex C, et al., 2005, Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 171, Pages: 1077-1082, ISSN: 1073-449X
- Author Web Link
- Cite
- Citations: 255
Lex C, Payne DNR, Zacharasiewicz A, et al., 2005, Sputum induction in children with difficult asthma: Safety, feasibility, and inflammatory cell pattern, PEDIATRIC PULMONOLOGY, Vol: 39, Pages: 318-324, ISSN: 8755-6863
- Author Web Link
- Cite
- Citations: 76
Erin EM, Leaker BR, Zacharasiewicz AS, et al., 2005, Single dose topical coticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge., Allergy, Vol: 60, Pages: 1524-1529
Erin EM, Zacharasiewicz AS, Nicholson GC, et al., 2005, Topical corticosteroid inhibits IL-4, IL-5 and IL-13 in nasal secretions following allergen challenge, Clinical and Experimental Allergy, Vol: 35, Pages: 1608-1614
Hansel T, Biberger C, Engelstätter R, 2004, Ciclesonide 80 μG or 320 μG once daily achieves lung function improvement comparable with budesonide 200 μG twice daily in patients with persistent asthma, Winter Meeting of the British-Thoracic-Society, Publisher: B M J PUBLISHING GROUP, Pages: 71-71, ISSN: 0040-6376
- Author Web Link
- Cite
- Citations: 2
Hansel TT, 2004, How do we measure the effectiveness of inhaled corticosteroids in clinical studies?, Respir Med, Vol: 98 Suppl B, Pages: S9-15, ISSN: 0954-6111
Inhaled corticosteroids (ICSs) are the gold standard anti-inflammatory therapy for asthma and have been studied using a variety of different clinical trial designs. In long-term comparative studies ICSs are more effective in controlling asthma than beta-agonists or leukotriene antagonists (LTAs). Efficacy has also been shown retrospectively, as patients frequently experience an exacerbation of their asthma upon withdrawal of ICSs, whilst the regular use of low dose ICSs prevents death from asthma. The combination of ICSs with long-acting beta2-agonists (LABAs) is effective for patients with asthma non-responsive to low doses of ICSs, particularly in reducing exacerbations. In shorter term studies a modest dose-response effect of ICSs has been shown for lung function, symptom control and oral corticosteroid use in asthmatic patients. ICSs are also effective in reducing airway hyperresponsiveness (AHR) to various stimuli, as well as reducing exhaled nitric oxide (NO) concentrations and the number and activation state of a wide variety of inflammatory cells. Finally, using allergen challenge models even single doses of ICSs have profound inhibitory effects on the late asthmatic reaction. Since ICSs are the mainstay of asthma management guidelines, it is important that novel therapies should be judged against ICSs in future clinical trials. There are many potential designs for these comparative studies.
Barnes PJ, Hansel TT, 2004, Prospects for new drugs for chronic obstructive pulmonary disease, LANCET, Vol: 364, Pages: 985-996, ISSN: 0140-6736
- Author Web Link
- Cite
- Citations: 142
Leckie MJ, Gomma AH, Purcell IF, et al., 2004, Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemia, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 95, Pages: 307-313, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 9
Hansel TT, Tennant RC, Tan AJ, et al., 2004, Theophylline: Mechanism of action and use in asthma and chronic obstructive pulmonary disease, DRUGS OF TODAY, Vol: 40, Pages: 55-69, ISSN: 1699-3993
- Author Web Link
- Cite
- Citations: 38
Hansel TT, Barnes PJ, 2004, An Atlas of Chronic Obstructive Pulmonary Disease, London, Publisher: Parthernon Publishing, ISBN: 9781842140048
Hansel TT, Tennant RC, Erin EM, et al., 2004, New drugs for COPD based on advances in pathology, Recent Advances in the Pathophysiology of COPD. Progress in Inflammation Research, Basel, Boston, Berlin, Publisher: Birkhauser
Barnes PJ, Erin EM, Hansel TT, et al., 2004, Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Designs, Pharmacology and Therapeutics of Asthma and COPD, Heidelberg, Publisher: Springer-Verlag
Tennant RC, Hansel TT, Hansell DM, 2004, Computed tomography (CT) scans in COPD, Recent Advances in the Pathophysiolgy of COPD. Progress in Inflammatory Research., Basel, Boston, Berlin, Publisher: Birkhauser
Hansel T, 2004, Recent Advances in the Pathophysiology of COPD. Progress in Inflammation Research., Basel, Boston, Berlin, Publisher: Birkhauser
Li AM, Lex C, Zacharasiewicz A, et al., 2003, Cough frequency in children with stable asthma: correlation with lung function, exhaled nitric oxide, and sputum eosinophil count, THORAX, Vol: 58, Pages: 974-978, ISSN: 0040-6376
- Author Web Link
- Cite
- Citations: 25
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.